[Catecholamine metabolism. Physiopathology and pathobiochemistry]

Area of Science:

• Biochemistry
• Pharmacology
• Cardiology

Context:

• Investigates the metabolism of vanillyl mandelic acid (VMA) and catecholamines in rat organs.
• Examines the influence of antiarrhythmic drugs on norepinephrine levels and cardiac function in vivo.
• Analyzes stress responses, including elevated plasma catecholamines and cortisol, in patients undergoing surgery and those with cardiac failure.

Purpose:

• To elucidate the enzymatic pathways involved in VMA metabolism in rat kidneys.
• To determine the effects of specific antiarrhythmic drugs (lidocaine, verapamil) on norepinephrine uptake and depletion in rat hearts.
• To assess the impact of emotional and physical stress on catecholamine levels in healthy volunteers and patients with cardiac conditions.

Summary:

• Rat kidney homogenates exhibit enzymatic activity for VMA dehydrogenation, suitable for kinetic studies.
• Verapamil inhibited norepinephrine uptake in rat hearts, while lidocaine did not affect tyramine-induced norepinephrine depletion.
• Emotional stress elevated plasma norepinephrine, cortisol, and free fatty acids, effects inhibited by diazepam and pentazocine.
• Patients with cardiac failure showed elevated norepinephrine levels and VMA excretion, responsive to antiarrhythmic drugs.
• Cardiac catecholamine overflow in atrial fibrillation patients was inhibited by antiarrhythmic drugs.
• Tumors of the adrenal cortex and medulla were associated with disturbed catecholamine and corticoid metabolism.

Impact:

• Provides insights into the biochemical mechanisms of catecholamine metabolism and stress response.
• Highlights the potential of antiarrhythmic drugs to modulate sympathetic nervous system activity.
• Demonstrates the link between stress, catecholamine levels, and cardiac function, particularly in pathological conditions.